Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors
Acta Pharmaceutica Sinica B · 2025-03 · 15 (3) · 1415-1429
DOI: 10.1016/j.apsb.2025.01.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2025-03. Verfasst von Xiong Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817, USA. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NCI NIH HHS, Office of Research and Development.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.
- Department of Urology, University of Washington, Seattle, DC 98915, USA.
- Department of Urologic Sciences, University of British Columbia, Vancouver, BC V5Z1M9, Canada.
- Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.
- Comprehensive Cancer Center, University of California Davis, Sacramento, CA 95817, USA.
- VA Northern California Health Care System-Mather, Mather, CA 95655, USA.
Förderung
- BLRD VA
- NCI NIH HHS
- Office of Research and Development
- DOD
- National Cancer Institute
- Prostate Cancer Foundation
- NIH
- Comprehensive Cancer Center, University of California, Davis
Zitieren
APA
Zhang, X., Yang, Y., Zou, H., Yang, Y., Zheng, X., Corey, E., Zoubeidi, A., Mitsiades, N., Yu, A. M., Li, Y., & Chen, H. W. (2025). Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors. Acta Pharmaceutica Sinica B, 15(3), 1415-1429. https://doi.org/10.1016/j.apsb.2025.01.007
Vancouver
Zhang X, Yang Y, Zou H, Yang Y, Zheng X, Corey E, et al. Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors. Acta Pharmaceutica Sinica B. 2025;15(3):1415-1429. doi:10.1016/j.apsb.2025.01.007
BibTeX
@article{Zhang2025,
author = {Zhang, Xiong and Yang, Yatian and Zou, Hongye and Yang, Yang and Zheng, Xingling and Corey, Eva and Zoubeidi, Amina and Mitsiades, Nicolas and Yu, Ai-Ming and Li, Yuanpei and Chen, Hong-Wu},
title = {Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors},
journal = {Acta Pharmaceutica Sinica B},
year = {2025},
volume = {15},
number = {3},
pages = {1415--1429},
doi = {10.1016/j.apsb.2025.01.007}
}
EUVIMED